Bridgeway Capital Management’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,010
| Closed | -$32.2K | – | 1184 |
|
|
2024
Q4 | $32.2K | Hold |
3,010
| – | – | ﹤0.01% | 1173 |
|
|
2024
Q3 | $39K | Sell |
3,010
-1,250
| -29% | -$16.2K | ﹤0.01% | 1226 |
|
|
2024
Q2 | $63.9K | Sell |
4,260
-1,300
| -23% | -$19.5K | ﹤0.01% | 1203 |
|
|
2024
Q1 | $156K | Hold |
5,560
| – | – | ﹤0.01% | 1146 |
|
|
2023
Q4 | $125K | Hold |
5,560
| – | – | ﹤0.01% | 1210 |
|
|
2023
Q3 | $116K | Buy |
5,560
+500
| +10% | +$10.4K | ﹤0.01% | 1199 |
|
|
2023
Q2 | $130K | Buy |
5,060
+1,300
| +35% | +$33.3K | ﹤0.01% | 1214 |
|
|
2023
Q1 | $105K | Sell |
3,760
-5,620
| -60% | -$156K | ﹤0.01% | 1231 |
|
|
2022
Q4 | $244K | Buy |
9,380
+3,720
| +66% | +$96.7K | 0.01% | 1035 |
|
|
2022
Q3 | $168K | Buy |
5,660
+2,385
| +73% | +$70.8K | ﹤0.01% | 1168 |
|
|
2022
Q2 | $134K | Sell |
3,275
-2,500
| -43% | -$102K | ﹤0.01% | 1171 |
|
|
2022
Q1 | $316K | Buy |
+5,775
| New | +$316K | 0.01% | 1060 |
|